Author | Ashish Saxena, MD, PhD | OncLive

Author | Ashish Saxena, MD, PhD

Articles

Dr. Saxena on the Future of Next-Generation ALK Inhibitors in NSCLC

January 31, 2020

Video

Ashish Saxena, MD, PhD, discusses the future of next-generation ALK inhibitors in non–small cell lung cancer.

Dr. Saxena on Available Next-Generation ALK Inhibitors in NSCLC

January 31, 2020

Video

Ashish Saxena, MD, PhD, discusses available next-generation ALK inhibitors in non–small cell lung cancer.

Dr. Saxena on the Importance of Initial Treatment Selection in ALK+ NSCLC

January 24, 2020

Video

Ashish Saxena, MD, PhD, discusses the importance of initial therapy selection in ALK-positive non–small cell lung cancer.

Dr. Saxena on the Importance of Biomarker Testing in ALK+ NSCLC

January 08, 2020

Video

Ashish Saxena, MD, PhD, discusses the importance of biomarker testing for stage IV ALK-positive non–small cell lung cancer.

x